Gene · 7399
Papers2,630
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 2,630
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Whole-exome sequencing screening for candidate genes and potential pathogenic variants associated with early-onset high myopia in 47 Chinese families. | Sci Rep | 2025 | 40175531 | PubTator, text mining | PubMed |
| Characterization of Visual Field Loss Over 4 Years in the Rate of Progression in USH2A-Related Retinal Degeneration (RUSH2A) Study. | Am J Ophthalmol | 2025 | 40157442 | PubTator, text mining | PubMed |
| The Progress and Evolving Trends in Nucleic-Acid-Based Therapies. | Biomolecules | 2025 | 40149911 | PubTator, text mining | PubMed |
| Exploring organoid and assembloid technologies: a focus on retina and brain. | Expert Rev Mol Med | 2025 | 40145178 | PubTator, text mining | PubMed |
| Deletion of the Human Cytomegalovirus US2 to US11 Gene Family Members Impairs the Type-I Interferon Response. | Viruses | 2025 | 40143353 | PubTator, text mining | PubMed |
| Rescue of the disease-associated phenotype in CRISPR-corrected hiPSCs as a therapeutic approach for inherited retinal dystrophies. | Mol Ther Nucleic Acids | 2025 | 40083649 | PubTator, text mining | PubMed |
| Landscape of small nucleic acid therapeutics: moving from the bench to the clinic as next-generation medicines. | Signal Transduct Target Ther | 2025 | 40059188 | PubTator, text mining | PubMed |
| Deciphering the largest disease-associated transcript isoforms in the human neural retina with advanced long-read sequencing approaches. | Genome Res | 2025 | 40037841 | PubTator, text mining | PubMed |
| Unraveling the Genetic Landscape of Hearing Loss: A Comprehensive Study of Azeri Families in Ardabil, Iran. | Mol Genet Genomic Med | 2025 | 39967327 | PubTator, text mining | PubMed |
| The importance of genetic counselling and testing in inherited eye diseases: A population-based retrospective study. | PLoS One | 2025 | 39946424 | PubTator, text mining | PubMed |
| Clinical and genetic landscape of IRD in Portugal: pooled data from the nationwide IRD-PT registry. | NPJ Genom Med | 2025 | 39939324 | PubTator, text mining | PubMed |
| Phenotypic Distinctions Between EYS- and USH2A-Associated Retinitis Pigmentosa in an Asian Population. | Transl Vis Sci Technol | 2025 | 39932467 | PubTator, text mining | PubMed |
| A Knockin Model with the Mouse Equivalent to the c.2299delG Mutation in Usherin Exhibits Early-Onset Hearing Loss and Progressive Retinal Degeneration. | Adv Exp Med Biol | 2025 | 39930205 | PubTator, text mining | PubMed |
| Characterizing the Genetic Basis for Inherited Retinal Disease: Lessons Learned From the Foundation Fighting Blindness Clinical Consortium's Gene Poll. | Invest Ophthalmol Vis Sci | 2025 | 39908130 | PubTator, text mining | PubMed |
| Quantification of Fundus Autofluorescence Features in a Molecularly Characterized Cohort of >3500 Patients with Inherited Retinal Disease from the United Kingdom. | Ophthalmol Sci | 2025 | 39896422 | PubTator, text mining | PubMed |
| Systematic empirical evaluation of individual base editing targets: Validating therapeutic targets in USH2A and comparison of methods. | Mol Ther | 2025 | 39881543 | PubTator, text mining | PubMed |
| Visual Acuity, Full-field Stimulus Thresholds, and Electroretinography for 4 Years in The Rate of Progression of USH2A-related Retinal Degeneration (RUSH2A) Study. | Ophthalmol Sci | 2025 | 39811264 | PubTator, text mining | PubMed |
| Genetic landscape in undiagnosed patients with syndromic hearing loss revealed by whole exome sequencing and phenotype similarity search. | Hum Genet | 2025 | 39755840 | PubTator, text mining | PubMed |
| The Effects of Pregnancy on Disease Progression of Retinitis Pigmentosa. | Am J Ophthalmol | 2025 | 39615819 | PubTator, text mining | PubMed |
| Prevalence of Molecular Diagnoses for Usher Syndrome and the Need for Coordinated Care. | Laryngoscope | 2025 | 39560289 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7399/papers?page=7